Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

48.54
Delayed Data
As of Jul 21
 +0.15 / +0.31%
Today’s Change
42.56
Today|||52-Week Range
70.92
-19.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues30.1M56.0M76.3M128.6M
 
 
 
 
 
Cost of Goods Sold10.0M11.5M12.7M48.8M
 
 
 
 
 
Depreciation And Amortization1.1M3.9M6.9M22.3M
 
 
 
 
 
 
Operating ExpensesGross Income19.0M40.6M56.7M57.5M
 
 
 
 
 
General Expenses12.6M20.6M24.0M30.7M
 
 
 
 
 
Research And Development1.7M2.7M2.9M2.9M
 
 
 
 
 
Total Operating Expenses23.7M36.0M43.6M101.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.4M20.0M32.7M26.8M
 
 
 
 
 
Extraordinary Charge-6.2M--0.00-6.7M
 
 
 
Interest Expense On Debt167.0K787.0K11.1M11.6M
 
 
 
 
 
Other Expenses95.0K160.0K41.0K-74.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income126.0K19.4M21.7M8.7M
 
 
 
 
 
Income Taxes-20.0K-9.4M-6.4M-4.7M
 
 
 
 
 
Preferred Dividend-5.0M0.000.000.00
 
 
Discontinued Operations195.0K0.000.000.00
 
 
Net Income301.0K28.6M15.3M3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.1M10.9M11.4M11.4M
 
 
 
 
 
Shares To Calculate EPS Diluted5.1M11.1M11.6M11.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.92$2.59$1.32$0.34
 
 
 
 
 
EPS Diluted-$0.92$2.59$1.32$0.34